Načítá se...
Targeting mutant p53 in cancer: the latest insights
This commentary wishes to highlight the latest discoveries in the mutant p53 field that have been discussed in the 8th p53 Mutant Workshop 2019, held in Lyon. TP53 mutant (mutp53) proteins are involved in the pathogenesis of most human cancers. Mutp53 proteins not only lose wild-typ53 function but,...
Uloženo v:
| Vydáno v: | J Exp Clin Cancer Res |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6612074/ https://ncbi.nlm.nih.gov/pubmed/31277687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-019-1302-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|